Cardiovascular Risks of Hydroxychloroquine vs Methotrexate in Patients With Rheumatoid Arthritis

MLA

Elvira D’Andrea, et al. “Cardiovascular Risks of Hydroxychloroquine vs Methotrexate in Patients With Rheumatoid Arthritis.” Journal of the American College of Cardiology, vol. 80, no. 1, Apr. 2022. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....3e48613198d0b82cd96a1e970bcc0836&authtype=sso&custid=ns315887.

APA

Elvira D’Andrea, Rishi J. Desai, Mengdong He, Robert J. Glynn, Hemin Lee, Michael E. Weinblatt, & Seoyoung C. Kim. (2022). Cardiovascular Risks of Hydroxychloroquine vs Methotrexate in Patients With Rheumatoid Arthritis. Journal of the American College of Cardiology, 80(1).

Chicago

Elvira D’Andrea, Rishi J. Desai, Mengdong He, Robert J. Glynn, Hemin Lee, Michael E. Weinblatt, and Seoyoung C. Kim. 2022. “Cardiovascular Risks of Hydroxychloroquine vs Methotrexate in Patients With Rheumatoid Arthritis.” Journal of the American College of Cardiology 80 (1). http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....3e48613198d0b82cd96a1e970bcc0836&authtype=sso&custid=ns315887.